Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT).
- Disclosed ownership: 10%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 10% ownership in 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 6.1% | 3,584,039 | 0 | 3,584,039 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 6.1% | 3,584,039 | 0 | 3,584,039 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 3.1% | 1,801,941 | 0 | 1,801,941 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 3.1% | 1,801,941 | 0 | 1,801,941 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.7% | 378,475 | 0 | 378,475 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.7% | 378,475 | 0 | 378,475 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 9.2% | 5,385,980 | 0 | 5,385,980 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 10% | 5,847,281 | 0 | 5,847,281 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 10% | 5,847,281 | 0 | 5,847,281 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 10% | 5,847,281 | 0 | 5,847,281 | /s/ Mark N. Lampert | Mark N. Lampert |